11:11 AM EDT, 06/29/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.60% to 1,888.94 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis ( CLLS ) and DBV Technologies ( DBVT ) , which advanced 6% and 2.7% respectively. Also rising were internet advertising firm Criteo ( CRTO ) and biotech company Evaxion ( EVAX ) , which increased 3.6% and 6.3% respectively.

The decliners from continental Europe were led by telecommunications operator Nokia ( NOK ) and medical device maker EDAP TMS ( FOCL ) , which fell 2.8% and 1% respectively. Anheuser-Busch InBev ( BUD ), which was off 1.2%.

The gainers from the UK were led by biopharmaceutical company NuCana ( NCNA ) and software firm Endava ( DAVA ) , which rose 3.2% and 2.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and oil and gas company BP (BP), which were up 1.4% and 1.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Akari Therapeutics ( AKTX ) , which lost 4.9% and 2.1% respectively. They were followed by biotech firmTrinity Biotech (TRIB), which dropped 0.3%.

Biopharmaceutical company Amarin ( AMRN ) was modestly higher.